Mark Hobraczk
            
            @mhobraczk.bsky.social
          
          130 followers
          310 following
          140 posts
        
          Ai Arthritis Director of Public Policy based in Tampa Bay.  Soccer dad and patient living with ankylosing spondylitis. University of Denver, JD.  George Washington, MPA.  Rutgers, BA. Opinions my own.
      
        Posts
        Media
        Videos
        Starter Packs
      
    
        
      Reposted by Mark Hobraczk
    
  
  
        
      Reposted by Mark Hobraczk
    
  
  
        
      Reposted by Mark Hobraczk
    
  
  
        
      Reposted by Mark Hobraczk
    
  
  
        
      Reposted by Mark Hobraczk
    
  
      FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary care setting.
https://www.medpagetoday.com/neurology/alzheimersdisease/117920
      
          https://www.medpagetoday.com/neurology/alzheimersdisease/117920
Alzheimer's Blood Test Cleared for Primary Care Use
          Elecsys pTau181 test can help rule out Alzheimer's-related amyloid pathology
        
          
          www.medpagetoday.com
        
      
  
        
      Reposted by Mark Hobraczk